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Abstract
The MYB transcription factor plays critical roles in normal and malignant haematopoiesis.
We previously showed that MYB was a direct activator of FLT3 expression within the con-
text of acute myeloid leukaemia. During normal haematopoiesis, increasing levels of FLT3
expression determine a strict hierarchy within the haematopoietic stem and early progenitor
compartment, which associates with lymphoid and myeloid commitment potential. We use
the conditional deletion of theMyb gene to investigate the influence of MYB in Flt3 transcrip-
tional regulation within the haematopoietic stem cell (HSC) hierarchy. In accordance with
previous report, in vivo deletion ofMyb resulted in rapid biased differentiation of HSC with
concomitant loss of proliferation capacity. We find that loss of MYB activity also coincided
with decreased FLT3 expression. At the chromatin level, the Flt3 promoter is primed in
immature HSC, but occupancy of further intronic elements determines expression. Binding
to these locations, MYB and C/EBPα need functional cooperation to activate transcription
of the locus. This cooperation is cell context dependent and indicates that MYB and C/
EBPα activities are inter-dependent in controlling Flt3 expression to influence lineage com-
mitment of multipotential progenitors.
Introduction
The HSC pool is phenotypically defined as KSL (KIT+ SCA-1+ LIN-) cells. This general classifi-
cation regroups cells that differ with respect to their capacity to reconstitute the haematopoietic
system in lethally irradiated mice. Continuing efforts to discriminate long- and short-term
HSC (LT-HSC, ST-HSC), multipotential progenitors (MPP) and lymphoid-primed multipo-
tential progenitors (LMPP) have identified different antibody-based strategies relying on the
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detection or absence of detection of several surface markers. One such strategy uses of a combi-
nation of the SLAMmarkers CD150, CD244, together with CD48 [1] and CD229 [2], another
utilises the differential expression or the receptors THY-1.1, VCAM-1 and CD62L within the
KSL population [3,4]. The combination of CD34 and FLT3 are used to segregate mouse
LT-HSC (KSL, CD34-, FLT3-) from ST-HSC (KSL, CD34+, FLT3-) and MPP (KSL, CD34+
FLT3+). In addition, the expression level of the FLT3 tyrosine kinase receptor can further sepa-
rate functional subpopulations of KSL cells [5]. In effect, increasing expression of FLT3, first
transcriptionally initiated in fully multi-potential HSC [6] distinguishes HSC, MPP and LMPP
[3,7]. This expression gradient associates with a functional role for the receptor, which contrib-
utes to the cell fate of multipotential progenitors. The role of FLT3 signalling in lineage com-
mitment has been extensively studied since targeted disruption of the Flt3 locus [8] and bone
marrow transplantation assays revealed a reduced ability of stem cells lacking FLT3 to contrib-
ute to both B cells and myeloid cells [9]. In line with these observations, FLT3hi LMPP give rise
to lymphocytes, granulocytes and macrophages but lack erythro-megakaryocytic potential
[10,11]. The studies using a knock out model for the FLT3 Ligand gene (Fl) proved most infor-
mative regarding the timing and function of FLT3 signalling in early lymphoid development.
Contrasting with normal levels of common myeloid progenitors (CMP) and granulocyte-
monocyte progenitors (GMP), the severely reduced number of common lymphoid progenitors
(CLP) in the Fl-/- animals led Sitnicka and colleagues to conclude that a principal function of
FLT3 signalling in steady-state haematopoiesis is to promote lymphoid commitment from a
multipotent progenitor/stem cell population [12]. Moreover, their follow-up study, comparing
Il7rα-/-, Fl-/- and the double knock out Il7rα-/- Fl-/- mice, elegantly demonstrated a key function
for FLT3 in the LMPP population, independently from IL-7Rα signalling [13]. Taking place at
the earliest stage of lymphoid development in the bone marrow, this non-redundant role is
essential to the establishment of transcriptional lymphoid priming, although subsequent
repression of Flt3 expression by PAX5 is paramount for B-cell development [14]. The signal-
ling pathway is also tightly controlled in myeloid cells where constitutive activation of the
FLT3 receptor provides a leukaemogenic signal and constitutes an adverse prognostic marker
in acute myeloid leukaemia (AML) [15,16]. In this leukaemic context, we previously reported
that MYB and C/EBPα proteins could both regulate FLT3 expression [17]. If this finding is
transferable in the HSC context, it raises the possibility that these factors may influence HSC
commitment potential through regulating FLT3 expression during normal haematopoiesis.
Extensive studies demonstrated that MYB plays an essential role during normal haemato-
poiesis. Mice homozygous for a knock out allele of theMyb gene die at embryonic day E15 as a
result of a failure to develop an adult blood system [18]. Thus, to facilitate further investigation
of the role of MYB in haematopoiesis, mouse models have been generated with knock down
(KD) [19,20], mutant alleles [21,22], or conditional inactivation of theMyb locus [19,23,24].
Together with chimera studies [25], these models have revealed that perturbation of MYB
activity affects haematopoietic stem cell (HSC) maintenance and activity [20,21,24] and skews
lineage commitment towards abnormal megakaryocytic and myelo-monocytic differentiation
[19,20,23,25–33].
Here, we use conditional deletion of theMyb gene [19], to clarify its role in Flt3 regulation
at the early stages of haematopoiesis. In line with previous reports, we find that, in two days,
loss of MYB expression leads to the exhaustion of HSC, which associates with an enhanced dif-
ferentiation rate and loss of proliferation potential. Within the KSL compartment, we show
thatMyb depletion results in a reduction of Flt3 expression, observable prior to HSC depletion.
The latter result could be recapitulated in a haematopoietic stem/progenitor cell line, in which
it was possible to demonstrate that the regulation of Flt3 transcription by MYB and C/EBPα
required their functional cooperation. This cooperative regulation involves cis-regulatory
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regions located in the Flt3 promoter and first intron, the occupancy of which directly correlates
with FLT3 expression in primary HSC.
Materials and Methods
Mice
TheMybF/F andMyb+/- mice are as described previously [18,19]. 8 week oldMybF/F:MxCre and
Myb+/+:MxCre littermates were injected with 250μg poly(I:C) (Sigma). The colony was main-
tained on a C57BL/6 background. Animal experiments were performed under a UK Home
Office Project License held by JF, which underwent ethical review through the University of
Birmingham ethical review committee. The study involved sacrifice of mice, performed by dis-
location of the neck as a Schedule 1 killing procedure according to UK Home Office
regulations.
Flow cytometry antibodies
Single-cell bone marrow suspensions were depleted from red cells by selective lysis. The lineage
cocktail including anti-CD5, CD8a, CD11b, B220, Gr1 and Ter119, FITC or APC conjugated
was combined with KIT_PE-Cy5 and SCA-1_PE-Cy7. Analysis of KSL subpopulations used
FLT3_PE, VCAM_eFlour450 and CD62L_APC (eBioscience). Analysis of LMPP presented in
S2 Fig was performed using SCA-1_APC, KIT_PE-Cy5, CD150_PE-Cy7, CD48_eFluor450
and FLT3_PE (eBioscience). Non-specific binding was prevented using anti-CD16/32, aside
from progenitor analysis where CD16/32_PE was used together with CD34_FITC and linea-
ge_APC (eBioscience).
Colony assays
For colony assay, 500 FACS-sorted KSL cells from bothMyb cKO and WTmice were seeded in
methylcellulose M3434 medium (Stem Cell Technologies Inc.). After 6 days, colonies were
counted and scored based on their size. For the differentiation assay, sorted KSL cells were cul-
tured for 48h in Iscove’s Modified Dulbecco Medium (IMDM) with 10% horse serum (Sigma-
Aldrich), L-glutamine (2 mM), penicillin (50U/ml), murine SCF (20ng/ml), FL (10ng/ml) and
TPO (5 ng/ml).
Nuclease hypersensitive site mapping
Cell nuclei were prepared in 1ml digestion buffer (15mM Tris-HCl pH7.5, 15mMNaCl, 60mM
KCl, 5mMMgCl2, 300mM glucose, 0.5mM EGTA, 0.1%NP40) and partially digested 10 min-
utes at 37°C with DNase I (0 to 60units). A stop solution (0330μl of 100mM EDTA / 4% SDS)
was added to terminate the reaction. RNA and proteins were sequentially digested at 37°C with
100μg RNase A (1hour) and 100μg proteinase K (overnight). Extracted DNA was used as tem-
plate for Q-PCR reactions. When using small numbers of cells, all volumes and quantities were
reduced by a scale factor of 2.5. Ratios between Q-PCR results from partially digested and
untreated samples (2-ΔCt) reflect the extent of nuclease sensitivity across regions covered by
PCR amplicons.
X-ChIP
X-ChIP assays were performed as previously described [34], using antibodies from Santa Cruz
Biotechnology and anti-MYB antibody from Upstate Ltd (Merck Millipore)
FLT3 Regulation in Haematopoietic Stem/Progenitor Cells
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Quantitative PCR
Q-PCR reactions forMyb, Flt3, Dntt, Il7rα, Notch1 and Hprt, gapdh and β2-microglobulin were
performed using predesigned Taqman gene expression assays (Applied Biosystems). Primers
for nuclease hypersensitivity assays and X-ChIP were previously described [17].
Transfections
For the HPC7 line, 5 x 106 cells were electroporated with up to 6μg of DNA using the Amaxa
3D-nucleofector with the solution L and program X-001, or the Amaxa 4D-nucleofector with
the SF cell line solution and the DS-120 program (Biosystems), respectively. C/EBPα and MYB
expressing plasmids or corresponding shRNA vectors (Origene) were co-transfected with a
GFP-encoding vector (Amaxa) and GFP-expressing cells were sorted on a MoFlo XDP cell
sorter (Beckman Coulter).
Transfections of primary cells were performed on a population enriched in bone marrow
KIT+ cells. Following the enrichment step using a MoFlo XDP cell sorter (Beckman Coulter),
the cells were cultured 2 hours prior to transfection in IMDMmedium supplemented with 5%
FBS, 50u/ml penicillin, 50μg/ml streptomycin, 0.1mM non-essential amino acids, 2mM L-glu-
tamine, 1mM sodium pyruvate, 50μM 2-mercaptoethanol, 10ng/ml GM-CSF, 25ng/ml SCF,
25ng/ml IL11, 10ng/ml IL3, 25ng/ml TPO and 4u/ml EPO. We used the Amaxa 3D-nucleofec-
tor with the solution P3 Primary Cells and program DS-138 to electroporate sets of 1 to 2 x 106
cells with 0.5μg of the Amaxa pmax GFP plasmid and 600nM siRNA in total. For the single
knockdowns 300ng ofMyb (s70212, Ambion—Lifetechnologies) or Cebpa siRNA (s63855,
Ambion- Lifetechnologies) were combined with 300nM of siRNA control (4390843 Silencer
Select Negative Control #1—Lifetechnologies) to maintain comparability with the double
knockdown results. Transfected cells were cultured for 20 hours in the aforementioned
IMDM-based medium, analysed by flow cytometry and GFP expressing KSL cells were sorted
for quantitative PCR analysis.
Luciferase assays
The reporter constructs HS-A/HS-B/Luc and HS-A/HS-B/luc/HS-C were generated by cloning
the Flt3 regulatory regions at positions -1459bp to +113bp (including HS-A and HS-B) and +-
7227bp to +8063bp (encompassing HS-C) with respect to the Flt3 ATG, into the pGL3 basic
vector (Invitrogen). HPC7 cells were electroporated with 3μg luciferase reporter construct, 2μg
expression vector for the MYB or C/EBPα factor or corresponding control vector, and 1μg of
β-galactosidase reporter plasmid. Luciferase activities were measured 24h later as previously
described [35]. Luciferase readings were normalised against β-galactosidase activity (Galacton
kit, Applera). Identical series of transfection were performed for each separate experiment and
results were normalised to 100 to allow comparability of the resulting patterns and minimise
artificial variability introduced by the use of different batches of reagents.
Statistical analysis
Statistical significance was determined by performing the Student’s t-test. The tests were paired
when relating to transfection experiments on cell lines. All t-tests were 2-tailed but for the lucif-
erase-based transactivation assay, for which the test was 1-tailed with a null hypothesis of no
increase in activity. The null hypothesis is rejected when p<0.05 and p values were graded with
stars as indicated in the caption of figures.
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Results
A 24 hour window permits investigation of early events followingMyb
gene deletion
A previous report from Lieu and Reddy [24] showed that in vivoMyb deletion results in HSC
depletion due to impaired proliferation and accelerated differentiation. To test if this system
could allow to investigate earlier phenotypes associated with loss of MYB function, we induced
conditional deletion of theMyb gene inMybF/F mice expressing CRE recombinase from the
MxCre transgene by means of poly(I:C) injections. As expected,Myb deletion resulted in a sig-
nificant decrease in bone marrow cellularity at 48 hours in comparison to theMyb+/+ control
littermates (data not shown) and a severe reduction of the relative proportion of the KSL popu-
lation (Fig 1A). However, these cellular losses were not seen at 24 hours post poly(I:C) injec-
tion. Annexin V staining confirmed that cell death was not increased within theMyb deleted
progenitors as previously reported [33] and demonstrated that apoptosis was neither changed
in KSL or LMPP-enriched compartments both at 24 hours and 48 hours post poly(I:C) injec-
tion (S1 Fig). To assess the behaviour of single cells at 24 hours post poly(I:C) injection, both in
terms of proliferation and differentiation, we plated sorted KSL cells from cKO and littermate
controls in semi solid medium sustaining multilineage haematopoietic differentiation. After 6
days in culture, the overall number of colonies formed byMyb cKO KSL cells and their WT
counterparts proved similar (Fig 1B). However, the deletion ofMyb resulted in a dramatic
decline in average colony size with a large number of small clusters of 1 to 4 cells generally dis-
playing megakaryocytic-like features (Fig 1B). Accordingly, when placed in liquid cultures,
Myb-deleted KSL cells underwent rapid differentiation, acquiring within 48 hours both mono-
cytic (CD11b) and megakaryocytic (CD41) characteristics, sometimes concomitantly (Fig 1C),
constituting an abnormal population known to be associated with theMyb KD and cKOmod-
els [20,24,33]. Thus, this model recapitulate the published characteristics ofMyb deleted cells
and offers a window of opportunity (24 hours post injection) to study the early phenotype asso-
ciated with the loss of MYB activity.
Myb deletion affects Flt3 expression in bone marrow HSC
We next analysed FLT3 expression in the KSL subset at 24 hours following conditional gene
deletion (Fig 2A). Immunofluorescence staining revealed a rise in FLT3- cells mirrored by a
sharp reduction in FLT3+ KSL in theMyb-deleted mice compared to their littermate controls
(Fig 2B upper panel). The observed changes in the FLT3+ and FLT3- fractions in the KSL popu-
lation could either reflect down-regulation of Flt3 expression, or be the indirect consequence of
an alteration in the balance between the KSL subpopulations, skewed towards an over-repre-
sentation of FLT3- immature cells. To distinguish between these possibilities by flow cytometry
without the need to use expression of FLT3, we employed the surface receptors CD34, VCAM-
1 and CD62L to discriminate the different components of the KSL population (Fig 2B). Our
analysis of KSL cells from animals undergoingMyb conditional deletion showed no significant
variation in the relative representation of the more immature KSL/CD34-, KSL/CD62L-, or
KSL/VCAM+ fractions compared to the control siblings (Fig 2B). In addition, we combined
staining strategies to further divide the KSL/CD62L+ subset based on VCAM-1 expression.
Again, the balance between the resulting sub-populations appeared similar in the presence and
absence of MYB within the 24-hour window. However, focusing on the KSL/CD62L+/VCAM-
population, highly enriched in LMPP that are normally FLT3hi, we confirmed thatMyb gene
deletion associates with a significant drop in FLT3 level at this time (Fig 2C). Finally, we con-
firmed this finding using a slam CD150 based strategy (S2 Fig). To examine changes in gene
FLT3 Regulation in Haematopoietic Stem/Progenitor Cells
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Fig 1. MYB deletion affects KSL cell number and differentiation. (A) Flow cytometric analysis of bone marrow fromMybF/F:MxCremutant mice and
Myb+/+:MxCre control animals, 24 or 48 hours following in vivo induction of theMybF/F allele deletion by p(I:C) injection. The representative two-dimensional
plots show the gating on lineage negative cells and the typical KIT+/SCA-1+/LIN- (KSL) staining. Histograms represent the percentage of KSL cells within the
total bone marrow population, with numbers presented as mean ± SEM, determined from 3 independent experiments (***, p<0.0001). (B) Control andMyb-
deleted KSL were sorted and seeded in methylcellulose. Colony numbers and size were assessed after 6 days. The right histograms represent total colony
FLT3 Regulation in Haematopoietic Stem/Progenitor Cells
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expression, KSL cells were sorted from the bone marrow of the cKO and control animals and
used for cDNA preparation. Mirroring the flow cytometry profiles, the Q-PCR analysis showed
a decrease in both Flt3 andMyb RNAs. Q-PCR analysis also highlighted a reduction in the lym-
phoid-associated transcripts Il7rα and Dntt, as reported by Greig and colleagues [30], but not
that of Notch1 (Fig 2D). Taken together, our results indicate that the observed decrease in
FLT3-expressing cells reflects a down-regulation of Flt3 rather than a change in the cellular dis-
tribution within the KSL compartment.
Occupancy of Flt3 intronic elements mirrors Flt3 expression in primary
KSL cells
To investigate Flt3 regulation in the context of uncommitted early progenitor cells, we applied
a similar approach that we used previously in the context of acute myeloid leukaemia [17]. For
this purpose, we made use of the multipotent haematopoietic progenitor cell line 7 (HPC7),
which was validated as a suitable model system for the analysis of transcriptional programs in
early progenitor cells [36,37]. Cell nuclei were treated with increasing quantities of DNaseI and
the extracted DNA were analysed by Q-PCR to outline the pattern of digestion. The calculation
of the ratio between digested and untreated samples revealed a greater amount of digestion at
three cis-regulatory regions; namely HS-A, HS-B and HS-C (Fig 3A). Remarkably, the overall
pattern appeared almost identical to that observed in the murine model for acute myeloid leu-
kaemia [17].
To test the relevance of our findings in primary cells, we assayed the nuclease sensitivity of
the three identified regions in primary haematopoietic stem/progenitor cells. Nuclei from
sorted primary KSL/Flt3- and KSL/Flt3+ cells, along with committed CMP (KIT+/SCA-1-/
LIN-/CD34+/CD16/32-), GMP (KIT+/SCA-1-/LIN-/CD34+/CD16/32+) and megakaryocyte-
erythroid progenitors (MEP) (KIT+/SCA-1-/LIN-/CD34-/CD16/32-) were used for DNaseI
assays. The results highlighted a change in nuclease sensitivity at the HS-C site that correlates
with the presence of the FLT3 receptor at the surface of the cells (Fig 3). Interestingly, the pro-
moter HS-A region displays hypersensitivity to DNaseI digestion prior to FLT3 protein detec-
tion (KSL/FLT3-), suggesting that the Flt3 promoter may be primed for swift activation,
mediated through the intronic HS-C region during the transition from ST-HSC to MPP. While
this “primed” profile is reinstated in the early stages (CMP and GMP) of the myelo-monocytic
lineage, the Flt3 promoter region appears to be “shut down” upon commitment to the mega-
karyocyte and erythroid lineages, along which FLT3 expression is never re-established.
MYB and C/EBPα functionally cooperate to regulate Flt3 expression in
stem/progenitor cells
To further investigate Flt3 regulation in uncommitted cells, we performed a series of X-ChIP
experiments in HPC7 and compared the results to our previous findings in myelogeneous leu-
kaemia [17]. The results demonstrated MYB, HOXA9 and MEIS1 binding to the Flt3 promoter
and revealed the co-recruitment of HOX-TALE partner protein PBX1 (but not PBX2) to the
HS-A regulatory module in the HSC-like cells (Fig 4). Contrasting with results obtained in the
AML context, we find that PU.1 binds promoter HS-A element of the Flt3 locus in the
numbers and the relative proportions of colonies based on size respectively. Pictures of the counted colonies are presented in the left panels. (C) Sorted KSL
from control andMyb-deleted animals 24 hours post injection of poly(I:C) were cultured into liquid medium containing SCF, FL and TPO. After culturing for 2
days, the cells were re-stained and analysed by flow cytometry for expression of CD11 and CD41 (left panel). Cells from theMybF/F:MxCre bone marrow
were sorted on the basis of CD11 and CD41. The sorted cells were spun onto glass slides and stained with Diff-Quick (upper right panel). The images show
representative cells demonstrating monocytic (CD11b+) and megakaryocytic (CD11b+CD41+ and CD11b-CD41+) morphologies.
doi:10.1371/journal.pone.0138257.g001
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Fig 2. InducedMyb ablation results in FLT3 down-regulation in a population highly enriched in LMPP. (A) Representative histogram and two-
dimensional flow cytometric plot analysis of cells in the KSL compartment of the bone marrow of the cKO and control mice 24 hours post poly(I:C) injection.
(B) The cells were further analysed for surface expression of FIT3 and the proportion of different KSL sub-fractions were assessed based on the surface
expression of VCAM-1 and CD62L. Regrouping 7 experiments, the right panel shows their relative contribution in percentage of the gated population,
indicated as plot header. (C) Serial gating defined a population highly enriched in LMPP (KSL/CD62L+/VCAM-) for which the percentage of FIT3hi cells was
FLT3 Regulation in Haematopoietic Stem/Progenitor Cells
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undifferentiated cells. Furthermore, C/EBPα associates with both HS-A and HS-C and co-
localises with MYB in HPC7 cells, whilst these factors are respectively restricted to the intronic
element and promoter in murine AML-like cells [17].
We next performed shRNA-mediated silencing or enforced expression to evaluate the con-
tribution of MYB and C/EBPα in the regulation of Flt3 expression in this cellular context (Fig
5A and 5B). Reduction of the expression of either theMyb or Cebpa genes led to corresponding
variations of Flt3 expression. However, in contrast with our observation in the AML-like cells,
over-expression of MYB or C/EBPα alone in the HSC-like cells failed to induce any change in
Flt3 transcript levels. Although, highlighting the need for a functional cooperation between the
two factors, enforced co-expression resulted in the up-regulation of the Flt3 gene (Fig 5C).
We next used luciferase reporter assays to test the relative contribution of the intronic
region in the realisation of this cooperative action. The promoter and upstream elements
(HS-B and HS-A) were placed upstream of the firefly luciferase reporter. In a second reporter
construct, the intronic region (HS-C) was further added downstream of the luciferase gene to
mimic its relative position with respect to the transcription start site (Fig 5D). In this artificial
setting, both proteins could up-regulate the reporter gene and displayed synergistic activity,
which was strengthened in the presence of the Flt3 intronic enhancer (Fig 5E). Of note, this
cooperative activity was not seen in a different cellular context provided by the 293T cells, in
which it appeared that the prime effect of C/EBPα was to counter-act MYB activating capacity
of the reporter, when co-expressed (S3 Fig).
Combined knock down of MYB and C/EBPα reduces FLT3 expression in
primary stem/progenitor cells
We investigated the in vivo effect of a reduced level of MYB on FLT3 expression by comparing
the percentage of FLT3+ KSL cells inMyb+/- mice and wild type littermates. Contrasting with
the results obtained in the conditional knock out system, theMyb haploinsufficient mice dis-
played normal amount of FLT3+ KSL cells (S4 Fig). We thus hypothesised that someMYB activ-
ity may suffice to maintain a normal expression level of FLT3. To test this hypothesis and
investigate the effect of reduced C/EBPα level on FLT3 expression in primary stem cells and
early progenitors, we proceeded to knock down their expression singly or in combination in a
KIT+ enriched bone marrow population. Twenty hours after siRNA introduction, the KSL com-
partment of the transfected cells was analysed to determine the percentage of FLT3+ cells. The
targeting ofMyb or Cebpa expression alone did not affect the overall expression of the FLT3
receptor (Fig 6A and 6B), despite an efficient reduction of the corresponding transcript levels,
which could be verified by quantitative PCR on cDNA from the sorted transfected KSL cells
(Fig 6C). However, the proportion of FLT3+ was significantly reduced when the expression of
both factors was reduced, suggesting that the combinatorial expression of MYB and C/EBPα
above a certain level is crucial for FLT3 regulation in primary HSC and early progenitor cells.
Discussion
We used conditional deletion of theMyb gene to analyse MYB influence on FLT3 expression
during normal haematopoiesis. As previously described [20,24,33], deletion of theMyb gene
results in the exhaustion of the HSC pool, observable at 48 hours following poly(I:C) injection.
measured. (D) Quantitative PCR analysis ofMyb, Flt3, Il7rα, Dntt and Notch1RNA expression in KSL cells isolated from the bone marrow of poly(I:C)-
inducedMyb cKOs and litter-mate controls 24 hours post injection. Expression is normalised to gapdh and standardised theMyb+/+:MxCre control samples,
set as 1. Error bars represent the standard error of the mean. Plots are representative of 7 independent experiments. Numbers are plotted as mean ± SEM
(***, p<0.0001 and **, p<0.01).
doi:10.1371/journal.pone.0138257.g002
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Fig 3. Flt3 intronic element hypersensitivity coincides with FLT3 expression in primary haematopoietic stem/progenitor cells.Upper panel gives a
schematic representation of the murine Flt3 promoter and first intron (filled box indicates exon1) and shows the level of cross-species sequence conservation
and the position of repeated sequences. The underlined regions A B and C indicate the general location of the regions of hypersensitivity to DNAseI digestion
in HPC7 cells. Lower panel plots show the assessment of DNaseI digestion sensitivity in the HPC7 cell line and in primary KSL FIT3+, KSL FIT3- cells, CMP
(LIN-/KIT+/SCA-1-/ CD34-/CD16/32+), GMP (LIN-/KIT+/SCA-1-/CD34+/CD16/32+) and MEP (LIN-/KIT+/SCA-1-/CD34-/CD16/32-). For primary cells, the
analysis are restricted to the digestion sites observed in HCP7 at -1.45 kb (HS-A), 0.15kb (HS-B) and +7.5kb (HS-C) from the murine Flt3 initiation codon.
doi:10.1371/journal.pone.0138257.g003
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Fig 4. Flt3 regulatory regions enable the recruitment of a combination of master regulators of haematopoiesis.Detection of in vivo transcription factor
binding at the sites of hypersensitivity to nuclease digestion was achieved by ChIP. Relative enrichments from X-ChIP material were determined against the
IgG control material by Q-PCR at the location of the hypersensitive regions and normalised against two internal control regions (located at -3.5kb and -0.27kb
from the ATG). Error bars represent the standard error of the mean. All plots are representative of a minimum of three independent experiments.
doi:10.1371/journal.pone.0138257.g004
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Fig 5. Genetic manipulation and reporter assay studies in HPC7 cells.Quantitative PCR analysis of gene expression in HPC7 cells following shRNA-
mediated silencing and ectopic expression of Myb (A) andCebpa (B). (C) Analysis of Flt3 transcript expression in HPC7 cells co-transfected withMyb and
Cebpa expression vectors or control plasmids. Determined by Q-PCR,Myb, Cebpa and Flt3 RNA levels were normalised againstGapdh abundance and
standardised against the corresponding control transfections. (D) Schematic representation of the reporter constructs in which Flt3 regulatory regions were
placed upstream (HS-A and HS-B) or downstream (HS-C) the luciferase gene. (E) Transactivation assays in HPC7 cells transfected with vector encoding for
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This feature is not seen at 24 hours but we could verify thatMyb deletion had already occurred
as, when cultured, the cells displayed greatly reduced proliferative capacity and accelerated dif-
ferentiation. At this earlier time, we could observe a reduction of FLT3+ cells and showed that
this diminution was neither the result of an increase in cell death nor a shift in the balance
between the KSL subpopulations. Interestingly, this phenotype only associates with a total loss
of expression in theMyb-deleted cells, as half dosage or further reduction ofMyb expression in
KSL cells did not result in any apparent change in FLT3 expression. It seems, therefore, that low
MYB activity could be sufficient to maintain FLT3 expression in these cells. Likewise, the down-
regulation of FLT3 expression in theMyb-deleted LMPP fraction of the bone marrow seemingly
contrasts with the fact that theMybPlt4/Plt4 mutant mice present normal levels of FLT3 expres-
sion. A notable particularity of the latter model is that the animals retain a small number of CLP
[32], which are typically lost uponMyb deletion. It thus constitutes an attractive model to study
MYB involvement in gene regulation associated with the lymphoid priming of multi-potential
progenitors and was used to pinpoint MYB-dependent Il7rα up-regulation as a crucial event
[31,32]. However, the ectopic expression of Il7rα failed to rescue lymphoid differentiation, sug-
gesting that MYBmay act at several levels to influence lineage commitment at this stage. The
reason whyMybPlt4/Plt4 LMPP display normal levels of FLT3 receptors may lay in the fact that
MYBPLT4 mutant protein retains some ability to regulate Flt3 expression. Alternatively, the com-
bined contribution of other regulators, including HOXA9, MEIS1, PBX1 C/EBPα and PU.1,
may adjust over time to compensate for the effect of perturbed MYBPLT4 activity on Flt3 regula-
tion. These key factors have a determining role for HSCmaintenance and function. Others have
previously demonstrated the role of HOXA9 in lympho-haematopoietic progenitor function
and Flt3 regulation [38]. PU.1 function was shown to be crucial during the transition from the
HSC to the earliest myeloid and lymphoid progenitors [39], whilst later stages of B-cell matura-
tion can progress in its absence. C/EBPα expression in multipotent HSC was identified as a
component of a flexible mechanism for lineage priming and fate commitment [40] and was
shown to participate in regulating HSC proliferative capacity [41,42]. We previously found that
both MYB and C/EBPα could independently activate FLT3 expression in AML [17]. Here, we
show that while single knock downs of either factor have no effect on FLT3 expression in pri-
mary KSL cells, co-silencing ofMyb and Cebpa expression leads to a reduction in the proportion
of the FLT3+ KSL cells. Using cell line models, we further highlight HSC-specific characteristics
that include the need for the functional cooperation of both factors in order to fully activate Flt3
transcription. Together with MYB, both C/EBPα and PU.1 were shown to cooperate in the regu-
lation of myeloid-specific genes such as myeloperoxidase and neutrophil elastase [43,44]. How-
ever, to our knowledge, this is the first example of such synergy in the HSC compartment. We
further demonstrate that the full realization of this cooperation involves the Flt3HS-C intronic
element. The significance of this region for Flt3 regulation is also highlighted at the transition
from HSC to multipotent progenitors. Using primary HSC and progenitor cells, we uncovered a
two-step mechanism underlying Flt3 regulation at the early stages of normal haematopoiesis.
Prior to detection of FLT3 expression at the cell surface, the accessibility of the promoter region
appears to reflect a primed state of the Flt3 gene in the most immature fraction of the HSC com-
partment. This open state of the Flt3 promoter, which is also seen in CMP and GMP, may allow
basal transcriptional activity and is consistent with previous studies reporting low levels of Flt3
RNA in KSL/FLT3- multipotent HSC and early GMP [45,46]. The accessibility to the intronic
site characterises the cells actively expressing the receptor.
MYB and C/EBPα proteins. Results were standardised to 100 and bars represent the average proportions across 4 experiments. All results are
representative of 3 or 4 independent experiments. P values representations: ***<0.001 and **<0.01.
doi:10.1371/journal.pone.0138257.g005
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Fig 6. Myb and Cebpa knockdown in primary KIT+ enriched bonemarrow cells. (A) Two-dimensional flow cytometry dot plot showing the analysis of the
KSL compartment of a KIT+ enriched population transfected with siRNA control or undergoing siRNA-mediated silencing ofMyb or Cebpa for 20 hours. (B)
Grouping four independent experiments, boxplots depict the variations in percentage of FLT3+ cells within the KSL populations. (C) Quantitative PCR
analysis ofMyb andCebpaRNA expression in sorted transfected KSL cells 20 hours post transfection. Expression is normalised to β2-microglobulin and
standardised to the control samples. Error bars represent the standard error of the mean. Plots are representative of 4 independent experiments. Numbers
are plotted as mean ± SEM (**, p<0.001 and *, p<0.05).
doi:10.1371/journal.pone.0138257.g006
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While the importance of MYB for LMPP function as been previously established, the mech-
anisms through which MYB influences lineage commitment at this stage are not clear. In fact,
both disruption theMyb gene and enforced expression of the protein in LMPP skews differen-
tiation towards myeloid rather than lymphoid cells [31]. We find that, together with an effect
on IL7rα, Flt3 up-regulation is another determinant of MYB-dependent molecular events
required for lymphoid priming of the MPP. We also find that, Flt3 transcriptional regulation in
uncommitted cells relies on a functional cooperation between MYB and C/EBPα.
Supporting Information
S1 Fig. InducedMyb deletion does not lead to increase apoptosis in KSL/progenitor cells.
Representative histogram and two-dimensional flow cytometric plot analysis of cells in the line-
age negative, progenitors and KSL compartment of the bone marrow of the cKO (MybF/F:MxCre)
and control (Myb+/+:MxCre) mice 24 (A) and 48 (B) hours post poly(I:C) injection. Histograms
represent the percentage of apoptotic cells within lineage negative, progenitor and KSL popula-
tions, with numbers presented as mean ± SEM, determined from 3 independent experiments.
(TIF)
S2 Fig. Analysis of the KLS compartment 24 hours post MYB deletion using the CD150/
CD48 strategy. Representative two-dimensional flow cytometric analysis of cells in the KSL
compartment of the bone marrow of the cKO (MybF/F:MxCre) and control (Myb+/+:MxCre)
mice 24 hours post p(I:C) injection. The proportion of LMPP-enriched KSL was assessed based
on the surface expression of CD48 and CD150. Serial gating defined a population highly
enriched in LMPP (CD150+/-CD48+KSL) for which the percentage of Flt3hi cells was measured.
Regrouping 3 independent experiments, the right panel shows the percentage of FLT3 expres-
sion in the gated population, indicated as plot header. Numbers are plotted as mean ± SEM
(, p<0.0001).
(TIF)
S3 Fig. Luciferase reporter studies in non-haematopoietic 293T cells. 293T cells were trans-
fected using the TransIT-293 kit, according to the manufacturer’s instructions (Mirus Bio)
with vectors encoding for MYB and C/EBPα proteins, together with the reporter constructs
shown in Fig 5. Results were standardised to 100 and bars represent the average proportions
across 3 experiments. All results are representative of 3 independent experiments.
(TIF)
S4 Fig. Percentage of FLT3+ KSL inMyb haploinsufficient mice and wild type counterparts.
Representative two-dimensional flow cytometry dot plots (upper panel) and box plot showing
depicting the variation in FLT3+ cells within the KSL compartment of wild type and MYB+/-
mice (lower panel).
(TIF)
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